Oncology Trials

Molecular Insight Pharmaceuticals currently has six oncology clinical trials underway:

Pheochromocytoma:

• A Study Evaluating Ultratrace Iobenguane I 131(MIBG) in Patients With Malignant Pheochromocytoma/Paraganglioma 
• Content Validation of Quality of Life and Symptom Questionnaires for Pheochromocytoma and Paraganglioma

Neuroblastoma:

• Phase 2a Study of Ultratrace™ Iobenguane I 131 in Patients With Relapsed or Refractory High-Risk Neuroblastoma 

Prostate Cancer

• A Study of 99mTc-MIP-1404 and 99mTc-MIP-1405 in Patients with Metastatic Prostate Adenocarcinoma and Healthy Volunteers 

Melanoma

• Phase I Safety and Dosimetry Study in Patients with Confirmed Metastatic Melanoma